Sign in

Steven Mizell

Director at AllegionAllegion
Board

About Steven C. Mizell

Independent director at Allegion plc since 2020 (tenure ~5.3 years) and Chair of the Compensation and Human Capital Committee since 2021; age 65. Former Executive Vice President and Chief Human Resources Officer (CHRO) at Merck (2018–2024) and Monsanto (2007–2018), with deep expertise in global human capital, succession, and compensation design . Holds a B.S. from Georgia Institute of Technology and an M.S. in Management from Carnegie Mellon University .

Past Roles

OrganizationRoleTenureCommittees/Impact
Merck & Co., Inc.Executive Vice President & CHRO2018–2024Led HR for ~68,000 global employees; responsible for talent, wellness, workplace culture
Monsanto CompanyExecutive Vice President & CHRO2007–2018Oversaw talent acquisition/development and DE&I; prior SVP, Human Resources (2004+)
AdvancePCSSenior Vice President & Chief Corporate Resources OfficerNot disclosedSenior HR leadership (pre‑Monsanto)

External Roles

OrganizationRoleDirector SinceCommittees
Group 1 Automotive, Inc. (NYSE: GPI)Director2021Compensation & Human Resources; Governance & Corporate Responsibility
GRAIL, Inc. (NASDAQ: GRAL)DirectorNot disclosedChair, Compensation; Member, Audit; Member, Nominating & Governance
Oshkosh Corporation (NYSE: OSK)Former DirectorNot disclosedChair, Human Resources Committee (prior)

Board Governance

  • Independence: Determined independent under NYSE rules; all committee members are independent .
  • Committee assignments: Chair, Compensation and Human Capital Committee; not listed as a member of Audit & Finance or Corporate Governance & Nominating in current committee table .
  • Attendance: Each nominee attended at least 87% of Board meetings and 100% of Committee meetings served in 2024; Board held 8 meetings; Compensation Committee held 5 .
  • Leadership structure: Board maintains separate independent Chair (Lauren Peters); independent director executive sessions held regularly at Board and Committee meetings .
  • Time-commitment policy: Non‑employee directors limited to no more than three other public company boards; Audit Committee members limited to no more than two other audit committees .
  • Shareholder feedback: 2024 say‑on‑pay received ~85% support; ongoing shareholder engagement program overseen by the Board and committees .
  • Policies supporting governance quality: Anti‑hedging/anti‑pledging (no directors/executives have pledged shares), enhanced clawback policy adopted in 2024 in addition to NYSE 10D‑1 compliant clawback .

Fixed Compensation

Component2024 AmountNotes
Cash Fees$169,393 Includes annual cash retainer and committee chair retainer (Compensation Chair increased to $25,000 effective June 6, 2024) and any special meeting fees
RSU Grant (Grant-date fair value)$130,053 Standard annual director RSUs; vest after one year, contingent on continued Board service
All Other Compensation$3,418 Includes dividend equivalents and Irish tax prep fees per policy
Total 2024 Director Compensation$302,864

Program parameters (effective June 6, 2024): Annual cash retainer $150,000; Compensation Chair retainer $25,000; special meeting fee $1,500; annual director RSUs $130,000; RSUs vest after one year .

Performance Compensation

Compensation Committee chaired by Mizell oversees executive incentive design; director pay itself is time‑based (no performance metrics). Key executive plan metrics and outcomes:

Metric (Corporate AIP, FY2024)ThresholdTargetMaximumActualWeighted AchievementPayout % of Target
Adjusted Revenue ($mm)3,651 3,794 3,984 3,734 26.32% 92.06% (corporate)
Adjusted Operating Income ($mm)793 857 943 842 29.45% 92.06% (corporate)
Adjusted Available Cash Flow ($mm)516 570 656 578 36.29% 92.06% (corporate)

PSU design and payout (2022–2024 performance period):

PSU MetricThresholdTargetMaximumActualEarned %
Adjusted EPS (FY2024)$6.02 $6.74 $7.72 $7.47 174%
TSR vs S&P 400/500 Capital Goods25th pct 50th pct ≥75th pct 30th pct (10.1% TSR) 60%
Combined PSU Payout117%

Committee practices: Benchmarking via updated peer group (added Graco, Sensata, SPX Technologies, nVent Electric, Watts Water, Resideo, Littelfuse for 2024), and independent consultant FW Cook engaged; enhanced clawback policy covers time‑based and performance awards beyond the SEC‑mandated scope .

Other Directorships & Interlocks

CompanyIndustry Adjacency to AllegionPotential Conflict
Group 1 AutomotiveAuto retail; limited direct overlap with Allegion’s security hardwareNone disclosed; subject to related‑party review process
GRAIL, Inc.Life sciences diagnostics; no apparent overlap with Allegion’s customer/supplier baseNone disclosed; subject to related‑party review process
Oshkosh Corporation (prior)Specialty vehicles/equipment; limited overlapNone disclosed

Related‑party transactions: None >$120,000 involving directors/executives since Jan 1, 2024 . Anti‑hedging/anti‑pledging policy prohibits hedging, pledging, margin accounts; no director/executive pledges outstanding .

Expertise & Qualifications

  • Human Capital Management; Strategy/M&A; Global Business/International; Industrial/Manufacturing; Innovation/Technology; Boards of other public companies .
  • Education: B.S. Georgia Tech; M.S. in Management, Carnegie Mellon University .
  • Committee leadership experience: Current Chair of Allegion Compensation & Human Capital Committee; Chair of Compensation at GRAIL; prior Chair of HR at Oshkosh .

Equity Ownership

ItemAmountNotes
Beneficial ownership (ordinary shares)4,463 shares <1% of outstanding (86,183,859 shares)
Notional shares (EDCP)None disclosed for Mizell
Options exercisable within 60 daysNone disclosed for Mizell
Unvested RSUs at 12/31/20241,105 RSUs Annual director RSUs vest after one year
Ownership guideline3× annual cash retainer; compliant/on track Directors must retain until retirement/departure
Shares pledged0Pledging prohibited; no director/executive pledges

Section 16 compliance: All required insider ownership reports timely filed in 2024 except one late Form 4 for a different director (Susan Main); no delinquent report noted for Mizell .

Governance Assessment

  • Strengths: Independent director with deep CHRO background; chairs Compensation & Human Capital Committee; strong attendance; rigorous policies (anti‑hedging/pledging; enhanced clawback); and structured ownership guidelines; 2024 say‑on‑pay support ~85% indicates acceptable investor alignment .
  • Oversight quality: Compensation design mixes adjusted EPS and relative TSR for PSUs and cash AIP tied to revenue/OI/ACF; clear pre‑set goals and formulaic payouts, with discretion for downward adjustments .
  • Potential watchpoints: 2022–2024 PSU payout at 117% despite TSR at only 30th percentile (EPS over‑achievement drove outcome), which can raise questions about relative performance alignment; however TSR is capped at target if absolute TSR is negative, and design uses dual metrics and broader S&P 400/500 peer set starting 2024 . Current external board load (two other public boards) remains within Allegion’s policy limits (≤3) .
  • Conflicts/related parties: No related‑party transactions disclosed; hedging/pledging prohibited and none outstanding; independence affirmed under NYSE standards .

Overall signal: Governance practices and committee leadership suggest solid board effectiveness and investor‑aligned policies; continued monitoring of compensation metric weighting vs. relative TSR outcomes is warranted as a Compensation Committee oversight topic chaired by Mizell .